The inhibitory effect of the tested compounds on melanoma cell viability was concentration-dependent with IC50 values ranging from 0.38 to 0.99 μg/mL (1.3 to 3.3 μM) for CDDP and from 0.016 to 0.901 μg/mL (0.03 to 1.7 μM) for MTO (Table 1). Here, SELENBP1 is linked to melanoma.